ODI Pharma AB(DE:6OD)
€0.18+-0.00 (+0.00%)
DE:6OD
ODI Pharma AB financials statements
€0.18
At close:+-0.00 (+0.00%)
ODI Pharma AB (6OD) Financial Statements
0 Followers
ODI Pharma AB Financial Overview
ODI Pharma AB's market cap is currently $3.58M. The company's EPS TTM is ―; its P/E ratio is 23.38; ODI Pharma AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ― | ― | ― | ― |
| Gross Profit | $ -103.64K | $ 0.00 | ― | ― |
| Operating Income | $ -7.21M | $ -3.96M | $ -4.93M | $ -3.34M |
| EBITDA | $ -7.20M | $ -3.95M | $ -4.92M | $ -3.34M |
| Net Income | $ -7.24M | $ -3.98M | $ -4.96M | $ -3.63M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | ― | ― | ― | ― |
| Total Assets | $ 10.50M | $ 16.88M | $ 20.86M | $ 4.47M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -7.37M | $ -14.62M | $ -20.51M | $ -4.42M |
| Total Liabilities | $ 1.24M | $ 581.73K | $ 785.67K | $ 425.99K |
| Stockholders' Equity | ― | ― | ― | ― |
| Cash Flow | ||||
| Free Cash Flow | $ -7.38M | $ -6.06M | $ -4.77M | $ -3.37M |
| Operating Cash Flow | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― |
Currency in USD
